These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9810372)

  • 1. [Coronary stents. Where are we? Where are we going?].
    Gaxiola E; Vlietstra RE; Pepine CJ
    Arch Inst Cardiol Mex; 1998; 68(4):337-45. PubMed ID: 9810372
    [No Abstract]   [Full Text] [Related]  

  • 2. Shifting the balance: direct stenting a novel approach to improve the cost effectiveness of intra-coronary stenting.
    Cotton JM; Kearney MT; Wainwright RJ
    Eur Heart J; 2000 Jan; 21(2):170. PubMed ID: 10637091
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary artery stents. American College of Cardiology.
    Pepine CJ; Holmes DR
    J Am Coll Cardiol; 1996 Sep; 28(3):782-94. PubMed ID: 8772772
    [No Abstract]   [Full Text] [Related]  

  • 4. Economics and outcomes of coronary stenting: are stents right for everybody?
    Weintraub WS
    J Invasive Cardiol; 2000 Apr; 12(4):200-2. PubMed ID: 10785673
    [No Abstract]   [Full Text] [Related]  

  • 5. Common sense, dollars and cents, and drug-eluting stents.
    Vaitkus PT
    J Am Coll Cardiol; 2006 Jul; 48(2):268-9. PubMed ID: 16843173
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical economic considerations of coronary stenting.
    Szucs TD
    Schweiz Med Wochenschr; 1999 Nov; 129(45):1701-11. PubMed ID: 10595380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dollars and sense of drug-eluting stents.
    Brophy JM
    CMAJ; 2005 Feb; 172(3):361-2. PubMed ID: 15684119
    [No Abstract]   [Full Text] [Related]  

  • 8. [The current status of the coronary stent].
    Macaya C
    Rev Clin Esp; 1993 May; 192(8):361-4. PubMed ID: 8511373
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic outcomes analysis of stenting versus percutaneous transluminal coronary angioplasty for patients with coronary artery disease in Japan.
    Ikeda S; Bosch J; Banz K; Schneller P
    J Invasive Cardiol; 2000 Apr; 12(4):194-9. PubMed ID: 10785672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
    J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of general usage of stents on short- and long-term health care costs following percutaneous coronary intervention.
    Odell A; Landelius P; Astrom-Olsson K; Grip L
    Cardiology; 2008; 109(2):85-92. PubMed ID: 17664872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coronary angioplasty: always a stent in arteries larger than 2.5 mm? The arguments con].
    Goicolea Ruigómez FJ; Macaya Miguel C
    Rev Esp Cardiol; 1999 Feb; 52(2):85-94. PubMed ID: 10073089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in coronary angioplasty.
    Bittl JA
    N Engl J Med; 1996 Oct; 335(17):1290-302. PubMed ID: 8857010
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombotic therapy after coronary-artery stenting.
    LoGerfo FW
    N Engl J Med; 1999 Apr; 340(17):1365-6; author reply 1367-8. PubMed ID: 10223874
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronary stenting: costly or cost-effective?
    Cohen DJ; Baim DS
    J Invasive Cardiol; 1995; 7 Suppl A():36A-42A. PubMed ID: 10155115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease.
    Elezi S; Dibra A; Folkerts U; Mehilli J; Heigl S; Schömig A; Kastrati A
    J Am Coll Cardiol; 2006 Jul; 48(2):262-7. PubMed ID: 16843172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.
    Reynolds MR; Neil N; Ho KK; Berezin R; Cosgrove RS; Lager RA; Sirois C; Johnson RG; Cohen DJ
    Am Heart J; 2003 Feb; 145(2):334-42. PubMed ID: 12595853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of percutaneous transluminal coronary angioplasty in Europe from 1992-1996.
    Maier W; Windecker S; Boersma E; Meier B
    Eur Heart J; 2001 Sep; 22(18):1733-40. PubMed ID: 11511123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What aspects are inefficient concerning percutaneous coronary intervention in Japan?: International cost-effectiveness comparisons].
    Chino M; Sakamoto M; Sasaki T; Isshiki T
    J Cardiol; 2004 Sep; 44(3):85-92. PubMed ID: 15500158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost analysis of percutaneous coronary intervention and coronary artery bypass grafting in Japan and USA].
    Chino M; Sasaki T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():632-7. PubMed ID: 12735043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.